Literature DB >> 14375712

[Isolated factor V deficiency caused by a specific inhibitor].

M H HORDER.   

Abstract

Entities:  

Keywords:  HEMORRHAGIC DIATHESIS

Mesh：

Year:  1955        PMID： 14375712     DOI： 10.1159/000204943

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  12 in total

1.  [The behavior of factor V in increased fibrinolysis].

Authors:  M H HOERDER
Journal:  Klin Wochenschr       Date:  1960-12-15

2.  Heparin-like anticoagulant occurring in association with chronic nephritis.

Authors:  A I CETINGIL; O N ULUTIN; M KARACA
Journal:  Br Med J       Date:  1959-07-11

3.  [Differential diagnosis of congenital Stuart factor deficiency].

Authors:  M H HORDER
Journal:  Klin Wochenschr       Date:  1959-04-15

4.  [New type of hemorrhagic diathesis. II].

Authors:  H E SCHULTZE; G SCHWICK
Journal:  Blut       Date:  1957-09

5.  [Thromboelastographical studies of various disorders of the preliminary and first phases of blood coagulation; a critical note on thromboelastography].

Authors:  F K BELLER; F KOCH; E MAMMEN
Journal:  Blut       Date:  1956-04

6.  [Blood platelets and coagulationactive plasma proteins. A short summary of their function and pathology].

Authors:  E MAMMEN; R GROSS
Journal:  Blut       Date:  1962-05

7.  Hemorrhagic varicella in parahemophilia.

Authors:  A Girolami; R Scarpa; P Cadrobbi
Journal:  Blut       Date:  1972-11

8.  [On substitution treatmentin congental factor V DEFICIENCY].

Authors:  G Winckelmann; C Walther
Journal:  Blut       Date:  1968-03

9.  Acquired factor v inhibitor developing after treatment with dabigatran etexilate methanesulfonate: a case report and review of the literature.

Authors:  Yasunobu Sekiguchi; Hitomi Yoshikawa; Asami Shimada; Hidenori Imai; Mutsumi Wakabayashi; Keiji Sugimoto; Noriko Nakamura; Tomohiro Sawada; Tetsuo Ichinose; Dai Ozaki; Norio Komatsu; Masaaki Noguchi
Journal:  Indian J Hematol Blood Transfus       Date:  2014-03-06       Impact factor: 0.900

10.  Correction by defects in clotting accelerator activity by administration of methionine and vitamin K and of a new sulfhydryl-substituted methylnaphthoquinone, vitamin K-S(II).

Authors:  J R CARTER; E D WARNER
Journal:  J Clin Invest       Date:  1958-01       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.